Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Patent CN102627573B details a high-yield synthesis of 5-aminolevulinic acid hydrochloride using 1,3-dichloroacetone, offering cost reduction and supply chain stability.
Novel binaphthyl phosphoric acid catalyzed synthesis of isoindolinone imines. High yield, mild conditions, suitable for commercial scale-up in pharmaceutical manufacturing.
Patent CN114478245A details a novel asymmetric synthesis method for chiral gamma-alkynyl-alpha-keto esters, offering high enantioselectivity and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN108558635B reveals a transition-metal-free route for 3-arylpropynoic acids using atmospheric CO2, offering significant cost reduction and supply chain reliability.
Patent CN101323576B reveals a green one-step synthesis of 4-nitro-1,8-naphthalic acid using CAN, offering significant cost reduction in fine chemical manufacturing and eliminating chromium pollution.
Novel synthesis method for axial chiral indole pyrrole-furan compounds with high enantioselectivity and yield, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN118878452B reveals novel antitumor compound synthesis. Offers mild conditions and high yield for pharmaceutical intermediate supply chains. Enables cost reduction in API manufacturing.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Enables cost reduction in pharmaceutical manufacturing and high-purity API supply chain reliability.
Novel protonic acid catalysis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN120172978B details a mild trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high-yield indoline pyrrole synthesis. Cost-effective scalable production for pharmaceutical intermediates supply chain.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Novel chiral phosphoric acid catalysis enables efficient indolocyclopentanes synthesis. Offers high selectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis route for chiral indolo oxa rings offers high yield and enantioselectivity. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable production capabilities.
Patent CN102260129A reveals a mild N-heterocyclic carbene catalyzed esterification. This technology offers significant cost reduction in ester manufacturing and enhanced supply chain reliability.
Patent CN102358715B details a low-toxicity cyanation method using potassium ferrocyanide, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.